Synthesis method for Nevirapine intermediates
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 上海思协化工科技有限公司
- Publication Date
- 2013-03-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention specifically relates to a synthetic method of an intermediate of nevirapine. Background technique
[0002] 2-Chloro-N-(2-chloro-4-methylpyridin-3-yl)nicotinamide is an important intermediate for the synthesis of nevirapine. Nevirapine is an anti-AIDS drug developed by Boehringer Ingelheim in Germany to prevent mother-to-child transmission of HIV. Nevirapine is a non-nucleoside reverse transcriptase inhibitor (Non-Nucleoside Reverse Transcriptase Inhibitor, NNRTI) of HIV-1. Nevirapine is directly linked to the reverse transcriptase of HIV-1 and blocks RNA-dependent and DNA-dependent DNA polymerase activity by breaking the catalytic end of the enzyme, thereby effectively reducing the number of viruses in the body and restoring human immune function. Nevirapine is currently one of the most widely used anti-AIDS drugs, mainly for the prevention and treatment of mother-to-child virus transmission. Therefore, it is of great significa...